A "Click Chemistry Platform" for the Rapid Synthesis of Bispecific Molecules for Inducing Protein Degradation
- J Med Chem. 2018 Jan 25;61(2):453-461. doi: 10.1021/acs.jmedchem.6b01781.
- 1. Department of Therapeutic Discovery-Discovery Technologies, Amgen Inc. , 1120 Veterans Boulevard, South San Francisco, California 94080, United States.
Proteolysis targeting chimeras (PROTACs) are bispecific molecules containing a target protein binder and an ubiquitin Ligase binder connected by a linker. By recruiting an ubiquitin Ligase to a target protein, PROTACs promote ubiquitination and proteasomal degradation of the target protein. The generation of effective PROTACs depends on the nature of the protein/Ligase ligand pair, linkage site, linker length, and linker composition, all of which have been difficult to address in a systematic way. Herein, we describe a "click chemistry" approach for the synthesis of PROTACs. We demonstrate the utility of this approach with the bromodomain and extraterminal domain-4 (BRD4) ligand JQ-1 (3) and ligase Binders targeting Cereblon (CRBN) and Von Hippel-Lindau (VHL) proteins. An AlphaScreen proximity assay was used to determine the ability of PROTACs to form the ternary ligase-PROTAC-target protein complex and a MSD assay to measure cellular degradation of the target protein promoted by PROTACs.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Ligands for E3 LigaseResearch Areas: Cancer
-
Research Areas: Cancer
-
Research Areas: Cancer
-
target: PROTAC LinkersResearch Areas: Cancer
-
target: PROTAC LinkersResearch Areas: Cancer
-
Research Areas: Cancer
-
Research Areas: Cancer
-
target: PROTAC LinkersResearch Areas: Cancer
-
target: PROTAC LinkersResearch Areas: Cancer
-
Research Areas: Cancer
-
target: PROTAC LinkersResearch Areas: Cancer